Status: Not yet recruiting
Eortc MoBilE Device (EMBED)
This study is a longitudinal observational study that will investigate the feasibility of using mobile devices for the assessment of HRQoL and physical activity in adult cancer patients undergoing treatment. Patients will complete a set of patient reported outcome measures (PROMs), and wear a smartwatch (min. 10 hours per day for one week), at baseline, and at weeks 4, 8 and 12 after treatment start.
Participants needed: 137
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: European Organisation for Research and Treatment of Cancer - EORTCUpdated: Jul 17, 2026
Eligibility criteria
Diagnosis of cancer [+8]
Exclusively receiving palliative care [+2]